Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DX25F6XRU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,357.40 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of Nucala 100 mg/ml auto-injectors. The delivery order carries an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026, which authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
The contract positions DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, leveraging its established portfolio of delivery orders for branded and generic prescription medications, biologics, and specialized medical consumables to military health facilities. This delivery order for Nucala auto-injectors—a biologic medication used for respiratory conditions—exemplifies the company's role in providing specialized pharmaceutical products directly to Department of Defense healthcare sites, maintaining continuity of supply for medications requiring frequent replenishment and specialized distribution capabilities.
Quick answers
Who was awarded contract SPE2DX25F6XRU?
SPE2DX25F6XRU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25F6XRU worth?
The government has obligated $11,357 on SPE2DX25F6XRU.
Is contract SPE2DX25F6XRU an order under another contract?
Yes. SPE2DX25F6XRU is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRU competed?
The extent of competition for SPE2DX25F6XRU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award